NDA/BLA filedconf 0.85

relacorilant — NDA/BLA filed

$CORT · CORCEPT THERAPEUTICS INC · hypertension secondary to hypercortisolism

Event date

June 17, 2026

40 days ago

Sponsor runway

5+ yrs

$338.2M liquid

Evidence

“On June 17, 2026, Corcept Therapeutics Incorporated (the "Company") issued a press release announcing that the Company has resubmitted its New Drug Application to the U.S. Food and Drug Administration for relacorilant as a treatment for patients with Cushing's syndrome.”

Source: 8-K filed 2026-06-17View on EDGAR ↗0001193125-26-274258

Comparable historical nda/bla fileds· last 5 years · same indication

Ticker	Drug	Date	Outcome
$CORT	relacorilant	2025-03-03	unknown

Recent insider activity· ±90 days

4 insiders · 0 buys · 5 sells

Gift

2026-05-13

Robb Gary Charles

Chief Business Officer

5,300 @ ——

Gift

2026-05-13

Robb Gary Charles

Chief Business Officer

1,000 @ ——

Sell10b5-1

2026-05-05

Guyer William

Chief Development Officer

20,000 @ $51.83$1.04M

Exercise10b5-1

2026-05-05

Guyer William

Chief Development Officer

20,000 @ $21.65$433K

Sell10b5-1

2026-05-01

BELANOFF JOSEPH K

Chief Executive Officer

40,000 @ $50.10$2.00M

Gift

2026-04-22

WILSON JAMES N

Director

2,000 @ ——

Sell10b5-1

2026-04-07

Guyer William

Chief Development Officer

20,000 @ $40.97$819K

Exercise10b5-1

2026-04-07

Guyer William

Chief Development Officer

20,000 @ $21.65$433K

Gift

2026-04-06

WILSON JAMES N

Director

5,000 @ ——

Sell10b5-1

2026-03-25

BELANOFF JOSEPH K

Chief Executive Officer

26,198 @ $50.07$1.31M

Exercise10b5-1

2026-03-20

Guyer William

Chief Development Officer

11,767 @ $21.65$255K

Sell10b5-1

2026-03-20

Guyer William

Chief Development Officer

11,767 @ $36.01$424K

Gift

2026-03-20

WILSON JAMES N

Director

4,000 @ ——

Date	Insider	Action	Shares	Price	Value
2026-05-13	Robb Gary CharlesChief Business Officer	Gift	5,300	—	—
2026-05-13	Robb Gary CharlesChief Business Officer	Gift	1,000	—	—
2026-05-05	Guyer WilliamChief Development Officer	Sell10b5-1	20,000	$51.83	$1.04M
2026-05-05	Guyer WilliamChief Development Officer	Exercise10b5-1	20,000	$21.65	$433K
2026-05-01	BELANOFF JOSEPH KChief Executive Officer	Sell10b5-1	40,000	$50.10	$2.00M
2026-04-22	WILSON JAMES NDirector	Gift	2,000	—	—
2026-04-07	Guyer WilliamChief Development Officer	Sell10b5-1	20,000	$40.97	$819K
2026-04-07	Guyer WilliamChief Development Officer	Exercise10b5-1	20,000	$21.65	$433K
2026-04-06	WILSON JAMES NDirector	Gift	5,000	—	—
2026-03-25	BELANOFF JOSEPH KChief Executive Officer	Sell10b5-1	26,198	$50.07	$1.31M
2026-03-20	Guyer WilliamChief Development Officer	Exercise10b5-1	11,767	$21.65	$255K
2026-03-20	Guyer WilliamChief Development Officer	Sell10b5-1	11,767	$36.01	$424K
2026-03-20	WILSON JAMES NDirector	Gift	4,000	—	—

← All catalysts for $CORT